Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Flipturn
United States
- New York City, New York
- 28/07/2023
- Seed
- $4,500,000
Flipturn’s mission is to accelerate electrification by helping fleets get the most out of their EVs. Our product, Flipturn Connect, is the first EV-focused fleet operations system combining data and insights across all of a fleet’s vehicles, chargers, and more. Connect enables you to smoothly adopt EVs at scale, while ensuring you have the visibility you need, all in one place. Spot problems quickly with a real-time dashboard, while also analyzing and lowering costs over time through detailed reports on driver efficiency, vehicle performance, utility costs, and more.
Interested in getting in touch? Email hello@getflipturn.com.
- Industry Software Development
- Website https://www.getflipturn.com/
- LinkedIn https://www.linkedin.com/company/flipturn-inc/
Related People
Katie SiegelCo Founder
United States -
Brooklyn, New York
Engineering leader with experience founding and growing early-stage teams. Angel investor in seed-stage startups. I'm passionate about climate, and excited about moving towards a zero-emissions future in transportation!
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)